Your browser doesn't support javascript.
loading
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.
Itonaga, Hidehiro; Kida, Michiko; Hamamura, Atsushi; Uchida, Naoyuki; Ozawa, Yukiyasu; Fukuda, Takahiro; Ueda, Yasunori; Kataoka, Keisuke; Katayama, Yuta; Ota, Shuichi; Matsuoka, Ken-Ichi; Kondo, Tadakazu; Eto, Tetsuya; Kanda, Junya; Ichinohe, Tatsuo; Atsuta, Yoshiko; Miyazaki, Yasushi; Ishiyama, Ken.
  • Itonaga H; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Kida M; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Hamamura A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Fukuda T; Department of Haematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ueda Y; Department of Hematology/Oncology and Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Okayama, Japan.
  • Kataoka K; Department of Medicine, Division of Hematology, Keio University School of Medicine, Tokyo, Japan.
  • Katayama Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Ota S; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Matsuoka KI; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kondo T; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Eto T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Kanda J; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Atsuta Y; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Miyazaki Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Ishiyama K; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagoya, Japan.
Hematol Oncol ; 40(4): 752-762, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35299289
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article